Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders (PRP/TMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03371888
Recruitment Status : Completed
First Posted : December 13, 2017
Last Update Posted : January 4, 2019
Sponsor:
Information provided by (Responsible Party):
Aleksandra Nitecka-Buchta, Medical University of Silesia

Brief Summary:
The Platelet-Rich Plasma intramuscular injections into the masseter and temporalis muscle were performed to reduce painful temporomandibular disorder symptoms,such as myalgia, myofascial pain and myofascial pain with referrals. Patients(n=120) were randomly divided into two groups: experimental(n=60) and control group(n=60). In controls injections with 0,9% NaCl were performed. Pain intensity was measured with NPRS (numeriic pain rating scale, 0= no pain, 11= the worst pain that one can imagine) before(0 day), during(10 day) and after(20 day) the therapy with PRP injections.

Condition or disease Intervention/treatment Phase
PRP Temporomandibular Disorder Myalgia Bruxism Biological: Platelet-Rich Plasma intramuscular injections Biological: Placebo Comparator: 0,9% NaCl intramuscular injections Phase 2 Phase 3

Detailed Description:
Patients(n=120) attending The Department of Temporomandibular Disorders and Orthodontics at the Silesian Medical University Poland, Zabrze were enrolled to the study and randomly divided into one of two groups: experimental and control group. Platelet-Rich Plasma(PRP) was prepared for each patient and an intramuscular injections of 0,5 ml PRP into 6 points at each side were performed in experimental group. A follow-up appointment was made after 10 and 20 days and in each visit an injection of PRP or 0,9% NaCl was performed. Pain intensity was measured in NPRS(numeric pain rating scale) and collected data data were analyzed.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 58 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: An intervention performed in experimental group and control group
Masking: Double (Participant, Care Provider)
Masking Description: double blinded study
Primary Purpose: Treatment
Official Title: The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders
Actual Study Start Date : December 7, 2017
Actual Primary Completion Date : December 15, 2018
Actual Study Completion Date : January 1, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: PRP injections
Intramuscular injection of Platelet-Rich Plasma into the masseter and temporalis muscle
Biological: Platelet-Rich Plasma intramuscular injections
A platelet-rich plasma intramuscular injections into the trigger points of painful muscles were performed.
Other Name: PRP intramuscular injections

Placebo Comparator: 0,9% NaCl injections
Intramuscular injection of 0,9% NaCl into the masseter and temporalis muscle
Biological: Placebo Comparator: 0,9% NaCl intramuscular injections
A 0,9% NaCl intramuscular injections into the trigger points of painful muscles were performed.
Other Name: Saline intramuscular injections




Primary Outcome Measures :
  1. Pain intensity reduction in VAS scale,(VAS scale 0-10 points) [ Time Frame: 14 days ]
    Decrease in pain intensity in masseter and temporalis muscles.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   23 Years to 42 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. presence of local myalgia, myofascial pain and myofascial pain with referral within masseter muscles according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) (II.1.A. 1, 2 and 3)
  2. patient's agreement for taking part into the research study

Exclusion Criteria:

  1. patients being treated with or addicted to analgesic drugs and/or drugs that affect muscle function
  2. presence of contraindications for injection therapy
  3. patients being treated by neurologist for neurological disorders and/or neuropathic pain and/or headache
  4. patients after traumas to the head and neck region in the previous 2 years
  5. edentulous patients
  6. patients after radiotherapy
  7. presence of severe mental disorders
  8. pregnancy or lactation
  9. pain of dental origin
  10. presence of malignancy
  11. drug and/or alcohol addiction
  12. patients with needle phobia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03371888


Locations
Layout table for location information
Poland
Department of TMD Silesian Medical University
Zabrze, Poland, 41-800
Sponsors and Collaborators
Medical University of Silesia
Investigators
Layout table for investigator information
Principal Investigator: Aleksandra Nitecka-Buchta, DMD Medical University of Silesia

Publications:

Layout table for additonal information
Responsible Party: Aleksandra Nitecka-Buchta, DMD, PhD, Medical University of Silesia
ClinicalTrials.gov Identifier: NCT03371888     History of Changes
Other Study ID Numbers: Silesian MU PRP
First Posted: December 13, 2017    Key Record Dates
Last Update Posted: January 4, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Temporomandibular Joint Disorders
Temporomandibular Joint Dysfunction Syndrome
Myalgia
Bruxism
Craniomandibular Disorders
Mandibular Diseases
Jaw Diseases
Musculoskeletal Diseases
Joint Diseases
Muscular Diseases
Stomatognathic Diseases
Myofascial Pain Syndromes
Tooth Diseases
Neuromuscular Diseases
Nervous System Diseases
Musculoskeletal Pain
Pain
Neurologic Manifestations
Signs and Symptoms